

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.20475374 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.20475374 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.56501853 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.56501853 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.85249241 |
| 6 | fatty acid elongation (GO:0030497) | 5.75095422 |
| 7 | axon ensheathment in central nervous system (GO:0032291) | 5.74390929 |
| 8 | central nervous system myelination (GO:0022010) | 5.74390929 |
| 9 | bile acid biosynthetic process (GO:0006699) | 5.14528540 |
| 10 | detection of molecule of bacterial origin (GO:0032490) | 4.81856734 |
| 11 | alpha-linolenic acid metabolic process (GO:0036109) | 4.66248656 |
| 12 | indole-containing compound catabolic process (GO:0042436) | 4.63953892 |
| 13 | indolalkylamine catabolic process (GO:0046218) | 4.63953892 |
| 14 | tryptophan catabolic process (GO:0006569) | 4.63953892 |
| 15 | glyoxylate metabolic process (GO:0046487) | 4.61955786 |
| 16 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.57194112 |
| 17 | kynurenine metabolic process (GO:0070189) | 4.42346490 |
| 18 | tryptophan metabolic process (GO:0006568) | 4.37219141 |
| 19 | bile acid metabolic process (GO:0008206) | 4.34645224 |
| 20 | protein carboxylation (GO:0018214) | 4.25949637 |
| 21 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.25949637 |
| 22 | regulation of fibrinolysis (GO:0051917) | 4.23042692 |
| 23 | complement activation, alternative pathway (GO:0006957) | 4.21750971 |
| 24 | negative regulation of fibrinolysis (GO:0051918) | 4.20821845 |
| 25 | hemidesmosome assembly (GO:0031581) | 4.16853657 |
| 26 | regulation of protein activation cascade (GO:2000257) | 4.16371017 |
| 27 | aromatic amino acid family metabolic process (GO:0009072) | 4.13299184 |
| 28 | tyrosine metabolic process (GO:0006570) | 4.11531989 |
| 29 | coenzyme catabolic process (GO:0009109) | 4.09793836 |
| 30 | high-density lipoprotein particle remodeling (GO:0034375) | 4.09554993 |
| 31 | very long-chain fatty acid metabolic process (GO:0000038) | 4.06754170 |
| 32 | cellular extravasation (GO:0045123) | 4.05128727 |
| 33 | urea cycle (GO:0000050) | 4.04672941 |
| 34 | urea metabolic process (GO:0019627) | 4.04672941 |
| 35 | negative regulation of protein activation cascade (GO:2000258) | 3.96895459 |
| 36 | cysteine metabolic process (GO:0006534) | 3.94515688 |
| 37 | regulation of complement activation (GO:0030449) | 3.90344142 |
| 38 | sulfur amino acid catabolic process (GO:0000098) | 3.87433406 |
| 39 | negative regulation of complement activation (GO:0045916) | 3.85725279 |
| 40 | cholesterol biosynthetic process (GO:0006695) | 3.82191801 |
| 41 | heme transport (GO:0015886) | 3.82034780 |
| 42 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.80083947 |
| 43 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.80083947 |
| 44 | modulation by symbiont of host immune response (GO:0052553) | 3.80083947 |
| 45 | positive regulation by symbiont of host defense response (GO:0052509) | 3.80083947 |
| 46 | modulation by symbiont of host defense response (GO:0052031) | 3.80083947 |
| 47 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.80083947 |
| 48 | macrophage activation involved in immune response (GO:0002281) | 3.79957250 |
| 49 | nitrogen cycle metabolic process (GO:0071941) | 3.79528690 |
| 50 | detection of external biotic stimulus (GO:0098581) | 3.75521295 |
| 51 | regulation of triglyceride catabolic process (GO:0010896) | 3.70136700 |
| 52 | plasma lipoprotein particle clearance (GO:0034381) | 3.68942485 |
| 53 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.68492149 |
| 54 | response to peptidoglycan (GO:0032494) | 3.66784950 |
| 55 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.65005334 |
| 56 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.64017941 |
| 57 | cofactor catabolic process (GO:0051187) | 3.63630329 |
| 58 | cellular ketone body metabolic process (GO:0046950) | 3.62422492 |
| 59 | cellular response to ethanol (GO:0071361) | 3.62315747 |
| 60 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.62036207 |
| 61 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.61724047 |
| 62 | opsonization (GO:0008228) | 3.61679179 |
| 63 | response to methylmercury (GO:0051597) | 3.61374967 |
| 64 | glutamate metabolic process (GO:0006536) | 3.61116904 |
| 65 | alpha-amino acid catabolic process (GO:1901606) | 3.61102915 |
| 66 | regulation of cholesterol esterification (GO:0010872) | 3.60310002 |
| 67 | neutrophil activation involved in immune response (GO:0002283) | 3.60179073 |
| 68 | detection of other organism (GO:0098543) | 3.58074291 |
| 69 | cholesterol efflux (GO:0033344) | 3.53959097 |
| 70 | amine catabolic process (GO:0009310) | 3.53224686 |
| 71 | cellular biogenic amine catabolic process (GO:0042402) | 3.53224686 |
| 72 | plasma lipoprotein particle remodeling (GO:0034369) | 3.52006512 |
| 73 | protein-lipid complex remodeling (GO:0034368) | 3.52006512 |
| 74 | macromolecular complex remodeling (GO:0034367) | 3.52006512 |
| 75 | ethanol oxidation (GO:0006069) | 3.50504844 |
| 76 | reverse cholesterol transport (GO:0043691) | 3.48678097 |
| 77 | triglyceride homeostasis (GO:0070328) | 3.45869099 |
| 78 | acylglycerol homeostasis (GO:0055090) | 3.45869099 |
| 79 | aldehyde catabolic process (GO:0046185) | 3.43412252 |
| 80 | sterol biosynthetic process (GO:0016126) | 3.37418240 |
| 81 | fibrinolysis (GO:0042730) | 3.36639779 |
| 82 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.34983177 |
| 83 | cellular amino acid catabolic process (GO:0009063) | 3.34301255 |
| 84 | indolalkylamine metabolic process (GO:0006586) | 3.33425273 |
| 85 | acetyl-CoA metabolic process (GO:0006084) | 3.32437458 |
| 86 | short-chain fatty acid metabolic process (GO:0046459) | 3.31167037 |
| 87 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.30247486 |
| 88 | cellular glucuronidation (GO:0052695) | 3.30076310 |
| 89 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.30058071 |
| 90 | neutrophil mediated immunity (GO:0002446) | 3.29623553 |
| 91 | regulation of bile acid biosynthetic process (GO:0070857) | 3.29446042 |
| 92 | bile acid and bile salt transport (GO:0015721) | 3.29256707 |
| 93 | ensheathment of neurons (GO:0007272) | 3.27977736 |
| 94 | axon ensheathment (GO:0008366) | 3.27977736 |
| 95 | serine family amino acid catabolic process (GO:0009071) | 3.27835929 |
| 96 | detection of biotic stimulus (GO:0009595) | 3.27825230 |
| 97 | negative regulation of lipase activity (GO:0060192) | 3.26748484 |
| 98 | negative regulation of humoral immune response (GO:0002921) | 3.26452943 |
| 99 | myelination (GO:0042552) | 3.25814130 |
| 100 | negative regulation of sterol transport (GO:0032372) | 3.25741205 |
| 101 | negative regulation of cholesterol transport (GO:0032375) | 3.25741205 |
| 102 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.24880109 |
| 103 | negative regulation of interleukin-12 production (GO:0032695) | 3.24448054 |
| 104 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.22336820 |
| 105 | serine family amino acid biosynthetic process (GO:0009070) | 3.22113103 |
| 106 | microglial cell activation (GO:0001774) | 3.20487136 |
| 107 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.20217102 |
| 108 | macrophage activation (GO:0042116) | 3.18099895 |
| 109 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.17868231 |
| 110 | ketone body metabolic process (GO:1902224) | 3.16253429 |
| 111 | phospholipid efflux (GO:0033700) | 3.15660494 |
| 112 | thioester biosynthetic process (GO:0035384) | 3.15305309 |
| 113 | acyl-CoA biosynthetic process (GO:0071616) | 3.15305309 |
| 114 | homocysteine metabolic process (GO:0050667) | 3.15085517 |
| 115 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.13234186 |
| 116 | L-serine metabolic process (GO:0006563) | 3.12624367 |
| 117 | thioester metabolic process (GO:0035383) | 3.12355786 |
| 118 | acyl-CoA metabolic process (GO:0006637) | 3.12355786 |
| 119 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.10395262 |
| 120 | aspartate family amino acid catabolic process (GO:0009068) | 3.09728582 |
| 121 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.08404887 |
| 122 | cholesterol homeostasis (GO:0042632) | 3.07430644 |
| 123 | iron coordination entity transport (GO:1901678) | 3.05150495 |
| 124 | low-density lipoprotein particle remodeling (GO:0034374) | 3.04800045 |
| 125 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.04270357 |
| 126 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.04270357 |
| 127 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.04132639 |
| 128 | sterol homeostasis (GO:0055092) | 3.02810753 |
| 129 | serine family amino acid metabolic process (GO:0009069) | 3.02091430 |
| 130 | detection of bacterium (GO:0016045) | 3.02030531 |
| 131 | imidazole-containing compound metabolic process (GO:0052803) | 3.01927788 |
| 132 | glucuronate metabolic process (GO:0019585) | 3.01143123 |
| 133 | neutrophil activation (GO:0042119) | 3.00403466 |
| 134 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.95125017 |
| 135 | negative regulation of cell killing (GO:0031342) | 2.95125017 |
| 136 | negative regulation of interleukin-17 production (GO:0032700) | 2.89981474 |
| 137 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.89978397 |
| 138 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.88659000 |
| 139 | regulation of gamma-delta T cell activation (GO:0046643) | 2.86929974 |
| 140 | T-helper 1 type immune response (GO:0042088) | 2.83937249 |
| 141 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.78929364 |
| 142 | granulocyte activation (GO:0036230) | 2.78788646 |
| 143 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.76104116 |
| 144 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.73403286 |
| 145 | negative regulation of B cell mediated immunity (GO:0002713) | 2.73352067 |
| 146 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.73352067 |
| 147 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.73119516 |
| 148 | iron ion import (GO:0097286) | 2.70614728 |
| 149 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.68822920 |
| 150 | response to host immune response (GO:0052572) | 2.68822920 |
| 151 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.65017264 |
| 152 | response to muramyl dipeptide (GO:0032495) | 2.64637185 |
| 153 | myeloid leukocyte mediated immunity (GO:0002444) | 2.63383926 |
| 154 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.59813623 |
| 155 | response to interleukin-15 (GO:0070672) | 2.59469131 |
| 156 | myeloid cell activation involved in immune response (GO:0002275) | 2.58534223 |
| 157 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.56424206 |
| 158 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.54801059 |
| 159 | negative regulation of T cell mediated immunity (GO:0002710) | 2.54514614 |
| 160 | regulation of interferon-alpha production (GO:0032647) | 2.54291249 |
| 161 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.54091383 |
| 162 | positive regulation of interferon-alpha production (GO:0032727) | 2.53133316 |
| 163 | germinal center formation (GO:0002467) | 2.52853442 |
| 164 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.49600037 |
| 165 | regulation of mast cell activation (GO:0033003) | 2.49558543 |
| 166 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.48632678 |
| 167 | response to host (GO:0075136) | 2.48632678 |
| 168 | response to host defenses (GO:0052200) | 2.48632678 |
| 169 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.48089878 |
| 170 | positive regulation of hemostasis (GO:1900048) | 2.47471330 |
| 171 | positive regulation of blood coagulation (GO:0030194) | 2.47471330 |
| 172 | positive regulation of coagulation (GO:0050820) | 2.45827598 |
| 173 | hypotonic response (GO:0006971) | 2.45751363 |
| 174 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.44849625 |
| 175 | cytokine secretion (GO:0050663) | 2.43512937 |
| 176 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.40988063 |
| 177 | regulation of humoral immune response (GO:0002920) | 2.40040327 |
| 178 | defense response to protozoan (GO:0042832) | 2.40010992 |
| 179 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.37130462 |
| 180 | negative regulation of adaptive immune response (GO:0002820) | 2.37059964 |
| 181 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.36689877 |
| 182 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.36471521 |
| 183 | growth hormone receptor signaling pathway (GO:0060396) | 2.35482895 |
| 184 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.34481003 |
| 185 | response to type I interferon (GO:0034340) | 2.33950221 |
| 186 | type I interferon signaling pathway (GO:0060337) | 2.33438016 |
| 187 | cellular response to type I interferon (GO:0071357) | 2.33438016 |
| 188 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.33234973 |
| 189 | positive regulation of mast cell activation (GO:0033005) | 2.32891443 |
| 190 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.30253839 |
| 191 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.30253839 |
| 192 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.28363281 |
| 193 | cellular response to interleukin-15 (GO:0071350) | 2.28257742 |
| 194 | regulation of acute inflammatory response (GO:0002673) | 2.28225821 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.98836295 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.92731133 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.42954675 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.13108445 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.92187556 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.66379020 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.60118543 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.40946577 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.27038719 |
| 10 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.92929658 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.84660572 |
| 12 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.80884048 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.66712021 |
| 14 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.66222066 |
| 15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.61949735 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.35745150 |
| 17 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.25065213 |
| 18 | * GBX2_23144817_ChIP-Seq_PC3_Human | 2.17325143 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.17298959 |
| 20 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.14675266 |
| 21 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.05207846 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.04989988 |
| 23 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.04468484 |
| 24 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.96822539 |
| 25 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.92140672 |
| 26 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.91570609 |
| 27 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.79163098 |
| 28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.78699615 |
| 29 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.75094342 |
| 30 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.73714418 |
| 31 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.66174503 |
| 32 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.64378682 |
| 33 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.62060761 |
| 34 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.56771608 |
| 35 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.51883654 |
| 36 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.51222381 |
| 37 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.49211663 |
| 38 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.49211663 |
| 39 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.48698951 |
| 40 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.47722713 |
| 41 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.45465755 |
| 42 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.45141168 |
| 43 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.44115511 |
| 44 | CJUN_26792858_Chip-Seq_BT549_Human | 1.43573907 |
| 45 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.41017702 |
| 46 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.40599902 |
| 47 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.40374003 |
| 48 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.37394598 |
| 49 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.34622666 |
| 50 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.34622666 |
| 51 | SPI1_23127762_ChIP-Seq_K562_Human | 1.34163394 |
| 52 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.31250161 |
| 53 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.31177096 |
| 54 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.30933582 |
| 55 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.28802249 |
| 56 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26180105 |
| 57 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.25405676 |
| 58 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.25350406 |
| 59 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.24061287 |
| 60 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.23976725 |
| 61 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.23616318 |
| 62 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.23072437 |
| 63 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.20879280 |
| 64 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.20040133 |
| 65 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.19916589 |
| 66 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.17369142 |
| 67 | GATA1_22025678_ChIP-Seq_K562_Human | 1.16498394 |
| 68 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.16250236 |
| 69 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.14675551 |
| 70 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.14151621 |
| 71 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.13431086 |
| 72 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.13431086 |
| 73 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13314233 |
| 74 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.13300500 |
| 75 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.12535255 |
| 76 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.11809609 |
| 77 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.11660089 |
| 78 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.11433683 |
| 79 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.11071318 |
| 80 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.10870287 |
| 81 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.10144994 |
| 82 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09727502 |
| 83 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.09069541 |
| 84 | P300_19829295_ChIP-Seq_ESCs_Human | 1.08535753 |
| 85 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.08264825 |
| 86 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.07716612 |
| 87 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07478601 |
| 88 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.07146305 |
| 89 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.07029837 |
| 90 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.06899942 |
| 91 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.06547616 |
| 92 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.05207798 |
| 93 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.05025336 |
| 94 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04936021 |
| 95 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.04353358 |
| 96 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.04011618 |
| 97 | MYB_26560356_Chip-Seq_TH2_Human | 1.03952879 |
| 98 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03948122 |
| 99 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.01991786 |
| 100 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.01827237 |
| 101 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.01259783 |
| 102 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.01027575 |
| 103 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.00962208 |
| 104 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.00754211 |
| 105 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.00078594 |
| 106 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.99727876 |
| 107 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.98008457 |
| 108 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.97700559 |
| 109 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.96219095 |
| 110 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95998882 |
| 111 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.95154167 |
| 112 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.94762740 |
| 113 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.94355207 |
| 114 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.94054703 |
| 115 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93949504 |
| 116 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93820467 |
| 117 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.93584721 |
| 118 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.93377044 |
| 119 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.93094705 |
| 120 | RXR_22108803_ChIP-Seq_LS180_Human | 0.92899212 |
| 121 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.92201277 |
| 122 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.89280544 |
| 123 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.89083268 |
| 124 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.88870028 |
| 125 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.87610233 |
| 126 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.85809126 |
| 127 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.85679575 |
| 128 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.85004319 |
| 129 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.84610094 |
| 130 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.84523873 |
| 131 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.84277402 |
| 132 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.84023398 |
| 133 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.83194171 |
| 134 | VDR_22108803_ChIP-Seq_LS180_Human | 0.81990924 |
| 135 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.80673538 |
| 136 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.80263630 |
| 137 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.79386149 |
| 138 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.79033379 |
| 139 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.78800692 |
| 140 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.78237699 |
| 141 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.78003149 |
| 142 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.77870467 |
| 143 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.77642437 |
| 144 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.77482162 |
| 145 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.77475664 |
| 146 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.77390596 |
| 147 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.77091248 |
| 148 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76791285 |
| 149 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.76569420 |
| 150 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.76484862 |
| 151 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.76445112 |
| 152 | TP53_16413492_ChIP-PET_HCT116_Human | 0.76295451 |
| 153 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.76128776 |
| 154 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.76128776 |
| 155 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.76014789 |
| 156 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.75915165 |
| 157 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.75799188 |
| 158 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.75724588 |
| 159 | KDM2B_26808549_Chip-Seq_REH_Human | 0.75431651 |
| 160 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.75422171 |
| 161 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.75228570 |
| 162 | CBP_21632823_ChIP-Seq_H3396_Human | 0.74232537 |
| 163 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.73386944 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.68761512 |
| 2 | MP0005360_urolithiasis | 5.98701497 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.12585932 |
| 4 | MP0005365_abnormal_bile_salt | 4.70933119 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.23979680 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.03416380 |
| 7 | MP0000569_abnormal_digit_pigmentation | 3.08407712 |
| 8 | MP0003195_calcinosis | 3.04581837 |
| 9 | MP0000920_abnormal_myelination | 3.02496291 |
| 10 | MP0003436_decreased_susceptibility_to | 2.86968679 |
| 11 | MP0003252_abnormal_bile_duct | 2.85729674 |
| 12 | MP0003303_peritoneal_inflammation | 2.83366418 |
| 13 | MP0009840_abnormal_foam_cell | 2.81006594 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.60739539 |
| 15 | MP0005083_abnormal_biliary_tract | 2.47822385 |
| 16 | MP0003690_abnormal_glial_cell | 2.41117561 |
| 17 | MP0001835_abnormal_antigen_presentation | 2.40710777 |
| 18 | MP0002419_abnormal_innate_immunity | 2.40253013 |
| 19 | MP0005332_abnormal_amino_acid | 2.27776479 |
| 20 | MP0006054_spinal_hemorrhage | 2.27108804 |
| 21 | MP0009785_altered_susceptibility_to | 2.17687483 |
| 22 | MP0005164_abnormal_response_to | 2.16208507 |
| 23 | MP0003329_amyloid_beta_deposits | 2.15023448 |
| 24 | MP0001666_abnormal_nutrient_absorption | 2.12918027 |
| 25 | MP0003300_gastrointestinal_ulcer | 2.11504554 |
| 26 | MP0003183_abnormal_peptide_metabolism | 2.01820726 |
| 27 | MP0002118_abnormal_lipid_homeostasis | 1.93707922 |
| 28 | MP0002148_abnormal_hypersensitivity_rea | 1.91293741 |
| 29 | MP0005025_abnormal_response_to | 1.89659569 |
| 30 | MP0005451_abnormal_body_composition | 1.85661221 |
| 31 | MP0004883_abnormal_blood_vessel | 1.83982933 |
| 32 | MP0001800_abnormal_humoral_immune | 1.78646258 |
| 33 | MP0005000_abnormal_immune_tolerance | 1.78156605 |
| 34 | MP0000604_amyloidosis | 1.78126019 |
| 35 | MP0001790_abnormal_immune_system | 1.77846736 |
| 36 | MP0005387_immune_system_phenotype | 1.77846736 |
| 37 | MP0003045_fibrosis | 1.76999949 |
| 38 | MP0005464_abnormal_platelet_physiology | 1.75217013 |
| 39 | MP0003950_abnormal_plasma_membrane | 1.73575439 |
| 40 | MP0003880_abnormal_central_pattern | 1.71110225 |
| 41 | MP0000685_abnormal_immune_system | 1.71055057 |
| 42 | MP0003868_abnormal_feces_composition | 1.65917878 |
| 43 | MP0001533_abnormal_skeleton_physiology | 1.65536631 |
| 44 | * MP0002723_abnormal_immune_serum | 1.65457531 |
| 45 | MP0003828_pulmonary_edema | 1.64501869 |
| 46 | MP0005671_abnormal_response_to | 1.62653172 |
| 47 | MP0002452_abnormal_antigen_presenting | 1.60391738 |
| 48 | MP0004947_skin_inflammation | 1.59906457 |
| 49 | MP0003172_abnormal_lysosome_physiology | 1.55400487 |
| 50 | MP0005409_darkened_coat_color | 1.54633198 |
| 51 | MP0003191_abnormal_cellular_cholesterol | 1.54412748 |
| 52 | MP0001851_eye_inflammation | 1.50630833 |
| 53 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.48505103 |
| 54 | MP0004381_abnormal_hair_follicle | 1.46104216 |
| 55 | MP0000609_abnormal_liver_physiology | 1.45105125 |
| 56 | MP0002420_abnormal_adaptive_immunity | 1.42000412 |
| 57 | MP0002405_respiratory_system_inflammati | 1.41716652 |
| 58 | MP0001819_abnormal_immune_cell | 1.40833816 |
| 59 | MP0008057_abnormal_DNA_replication | 1.35229535 |
| 60 | MP0004019_abnormal_vitamin_homeostasis | 1.33118378 |
| 61 | MP0004270_analgesia | 1.31320682 |
| 62 | MP0002168_other_aberrant_phenotype | 1.31176867 |
| 63 | MP0004142_abnormal_muscle_tone | 1.29025628 |
| 64 | MP0003566_abnormal_cell_adhesion | 1.27428981 |
| 65 | MP0005023_abnormal_wound_healing | 1.27421400 |
| 66 | MP0003656_abnormal_erythrocyte_physiolo | 1.27080276 |
| 67 | MP0003453_abnormal_keratinocyte_physiol | 1.24175449 |
| 68 | MP0003011_delayed_dark_adaptation | 1.22359048 |
| 69 | MP0001845_abnormal_inflammatory_respons | 1.20760869 |
| 70 | MP0001661_extended_life_span | 1.18568648 |
| 71 | MP0004885_abnormal_endolymph | 1.17969179 |
| 72 | MP0005310_abnormal_salivary_gland | 1.17403574 |
| 73 | MP0003632_abnormal_nervous_system | 1.17248069 |
| 74 | MP0005397_hematopoietic_system_phenotyp | 1.17111899 |
| 75 | MP0001545_abnormal_hematopoietic_system | 1.17111899 |
| 76 | MP0000015_abnormal_ear_pigmentation | 1.16889293 |
| 77 | MP0000371_diluted_coat_color | 1.16287618 |
| 78 | MP0010155_abnormal_intestine_physiology | 1.14729824 |
| 79 | MP0005319_abnormal_enzyme/_coenzyme | 1.11575286 |
| 80 | MP0005408_hypopigmentation | 1.11026010 |
| 81 | MP0002332_abnormal_exercise_endurance | 1.10949476 |
| 82 | MP0001764_abnormal_homeostasis | 1.09665879 |
| 83 | MP0001905_abnormal_dopamine_level | 1.07456467 |
| 84 | MP0009697_abnormal_copulation | 1.06494709 |
| 85 | MP0005275_abnormal_skin_tensile | 1.06312239 |
| 86 | MP0003634_abnormal_glial_cell | 1.05561214 |
| 87 | MP0002998_abnormal_bone_remodeling | 1.04916863 |
| 88 | MP0005174_abnormal_tail_pigmentation | 1.04910684 |
| 89 | MP0000465_gastrointestinal_hemorrhage | 1.04424582 |
| 90 | MP0002272_abnormal_nervous_system | 1.03891265 |
| 91 | MP0001529_abnormal_vocalization | 1.02823852 |
| 92 | MP0000858_altered_metastatic_potential | 1.02724577 |
| 93 | MP0002064_seizures | 1.02094375 |
| 94 | MP0001216_abnormal_epidermal_layer | 1.01113764 |
| 95 | MP0001486_abnormal_startle_reflex | 1.00801970 |
| 96 | MP0004484_altered_response_of | 0.99366267 |
| 97 | MP0000716_abnormal_immune_system | 0.98838528 |
| 98 | MP0002138_abnormal_hepatobiliary_system | 0.98807154 |
| 99 | MP0005166_decreased_susceptibility_to | 0.98233363 |
| 100 | MP0005167_abnormal_blood-brain_barrier | 0.97655449 |
| 101 | MP0003091_abnormal_cell_migration | 0.97288467 |
| 102 | MP0005171_absent_coat_pigmentation | 0.97121639 |
| 103 | MP0010678_abnormal_skin_adnexa | 0.94434552 |
| 104 | MP0003136_yellow_coat_color | 0.94344349 |
| 105 | MP0004742_abnormal_vestibular_system | 0.93338818 |
| 106 | MP0003631_nervous_system_phenotype | 0.93176328 |
| 107 | MP0010234_abnormal_vibrissa_follicle | 0.92919002 |
| 108 | MP0000427_abnormal_hair_cycle | 0.92603553 |
| 109 | MP0000249_abnormal_blood_vessel | 0.92073718 |
| 110 | MP0003448_altered_tumor_morphology | 0.92047645 |
| 111 | MP0002822_catalepsy | 0.91990615 |
| 112 | MP0001853_heart_inflammation | 0.91251470 |
| 113 | MP0002229_neurodegeneration | 0.90757057 |
| 114 | MP0004043_abnormal_pH_regulation | 0.88945267 |
| 115 | MP0005647_abnormal_sex_gland | 0.88854357 |
| 116 | MP0002396_abnormal_hematopoietic_system | 0.87570641 |
| 117 | MP0001915_intracranial_hemorrhage | 0.86558766 |
| 118 | MP0003633_abnormal_nervous_system | 0.86357405 |
| 119 | MP0003763_abnormal_thymus_physiology | 0.86054608 |
| 120 | MP0004859_abnormal_synaptic_plasticity | 0.86053529 |
| 121 | MP0006082_CNS_inflammation | 0.84602933 |
| 122 | MP0009745_abnormal_behavioral_response | 0.84292614 |
| 123 | MP0009278_abnormal_bone_marrow | 0.80412893 |
| 124 | MP0009765_abnormal_xenobiotic_induced | 0.80260811 |
| 125 | MP0000579_abnormal_nail_morphology | 0.79807788 |
| 126 | MP0003075_altered_response_to | 0.78530397 |
| 127 | MP0002398_abnormal_bone_marrow | 0.78234435 |
| 128 | MP0009384_cardiac_valve_regurgitation | 0.78211106 |
| 129 | MP0003186_abnormal_redox_activity | 0.77666818 |
| 130 | MP0002132_abnormal_respiratory_system | 0.77548776 |
| 131 | MP0005410_abnormal_fertilization | 0.77054765 |
| 132 | MP0009763_increased_sensitivity_to | 0.76738433 |
| 133 | MP0008438_abnormal_cutaneous_collagen | 0.76020106 |
| 134 | * MP0002060_abnormal_skin_morphology | 0.75656383 |
| 135 | MP0005075_abnormal_melanosome_morpholog | 0.73733512 |
| 136 | MP0000639_abnormal_adrenal_gland | 0.73019038 |
| 137 | MP0005551_abnormal_eye_electrophysiolog | 0.72539044 |
| 138 | MP0000383_abnormal_hair_follicle | 0.70979269 |
| 139 | MP0009643_abnormal_urine_homeostasis | 0.70418505 |
| 140 | MP0004147_increased_porphyrin_level | 0.68699065 |
| 141 | MP0000462_abnormal_digestive_system | 0.68411103 |
| 142 | MP0002295_abnormal_pulmonary_circulatio | 0.67008923 |
| 143 | MP0008874_decreased_physiological_sensi | 0.67007720 |
| 144 | MP0009764_decreased_sensitivity_to | 0.66929234 |
| 145 | MP0003635_abnormal_synaptic_transmissio | 0.66745353 |
| 146 | MP0005636_abnormal_mineral_homeostasis | 0.66173313 |
| 147 | MP0008260_abnormal_autophagy | 0.65988509 |
| 148 | MP0005058_abnormal_lysosome_morphology | 0.64978353 |
| 149 | MP0000778_abnormal_nervous_system | 0.64863879 |
| 150 | MP0005535_abnormal_body_temperature | 0.64861039 |
| 151 | MP0002090_abnormal_vision | 0.64517462 |
| 152 | MP0000647_abnormal_sebaceous_gland | 0.64499242 |
| 153 | MP0002876_abnormal_thyroid_physiology | 0.62237229 |
| 154 | MP0000566_synostosis | 0.60274367 |
| 155 | MP0001440_abnormal_grooming_behavior | 0.58872419 |
| 156 | MP0009046_muscle_twitch | 0.58815665 |
| 157 | MP0003724_increased_susceptibility_to | 0.57687490 |
| 158 | MP0002572_abnormal_emotion/affect_behav | 0.57486596 |
| 159 | MP0001177_atelectasis | 0.57129748 |
| 160 | MP0000598_abnormal_liver_morphology | 0.56111888 |
| 161 | MP0005376_homeostasis/metabolism_phenot | 0.55804680 |
| 162 | MP0001485_abnormal_pinna_reflex | 0.55020517 |
| 163 | MP0009642_abnormal_blood_homeostasis | 0.52890933 |
| 164 | MP0002063_abnormal_learning/memory/cond | 0.52142926 |
| 165 | MP0008469_abnormal_protein_level | 0.51989326 |
| 166 | MP0001346_abnormal_lacrimal_gland | 0.48698311 |
| 167 | MP0002066_abnormal_motor_capabilities/c | 0.47689469 |
| 168 | MP0000467_abnormal_esophagus_morphology | 0.47069103 |
| 169 | MP0002971_abnormal_brown_adipose | 0.47068648 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.64769137 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.63664166 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.05614921 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 5.50027672 |
| 5 | Xanthomatosis (HP:0000991) | 5.15821063 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.01189412 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.89158661 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 4.87720804 |
| 9 | Orchitis (HP:0100796) | 4.59515387 |
| 10 | Retrobulbar optic neuritis (HP:0100654) | 4.46543737 |
| 11 | Optic neuritis (HP:0100653) | 4.46543737 |
| 12 | Complement deficiency (HP:0004431) | 4.35204046 |
| 13 | Neurofibrillary tangles (HP:0002185) | 4.30955433 |
| 14 | Myositis (HP:0100614) | 4.24915403 |
| 15 | Thick nail (HP:0001805) | 4.20390926 |
| 16 | Recurrent bacterial skin infections (HP:0005406) | 4.12604247 |
| 17 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.89842150 |
| 18 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.89842150 |
| 19 | Abnormality of methionine metabolism (HP:0010901) | 3.88760248 |
| 20 | Epidermoid cyst (HP:0200040) | 3.75835637 |
| 21 | Fat malabsorption (HP:0002630) | 3.67566744 |
| 22 | Recurrent abscess formation (HP:0002722) | 3.66806076 |
| 23 | Keratoconjunctivitis sicca (HP:0001097) | 3.60168480 |
| 24 | Milia (HP:0001056) | 3.58330095 |
| 25 | Joint hemorrhage (HP:0005261) | 3.55076117 |
| 26 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.53912976 |
| 27 | Eczematoid dermatitis (HP:0000976) | 3.46223424 |
| 28 | Keratoconjunctivitis (HP:0001096) | 3.44734318 |
| 29 | Hypolipoproteinemia (HP:0010981) | 3.43384357 |
| 30 | Plantar hyperkeratosis (HP:0007556) | 3.40111098 |
| 31 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.38907643 |
| 32 | Abnormality of the common coagulation pathway (HP:0010990) | 3.38101171 |
| 33 | Hyperammonemia (HP:0001987) | 3.35782612 |
| 34 | Conjugated hyperbilirubinemia (HP:0002908) | 3.31643794 |
| 35 | Cerebral inclusion bodies (HP:0100314) | 3.26466182 |
| 36 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.23093942 |
| 37 | Hyperglycinemia (HP:0002154) | 3.22122404 |
| 38 | Abnormality of the corticospinal tract (HP:0002492) | 3.19669644 |
| 39 | Onycholysis (HP:0001806) | 3.17146016 |
| 40 | Ketosis (HP:0001946) | 3.13537027 |
| 41 | Stomatitis (HP:0010280) | 3.11608539 |
| 42 | Abnormality of nail color (HP:0100643) | 3.09391729 |
| 43 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.09304243 |
| 44 | Steatorrhea (HP:0002570) | 3.08490011 |
| 45 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.05781058 |
| 46 | Abnormality of glycine metabolism (HP:0010895) | 3.05781058 |
| 47 | Abnormality of macrophages (HP:0004311) | 3.01774813 |
| 48 | Alopecia of scalp (HP:0002293) | 3.00646271 |
| 49 | Congenital sensorineural hearing impairment (HP:0008527) | 2.99604686 |
| 50 | Recurrent skin infections (HP:0001581) | 2.98965850 |
| 51 | Gangrene (HP:0100758) | 2.95687660 |
| 52 | Parakeratosis (HP:0001036) | 2.94434843 |
| 53 | Abnormality of complement system (HP:0005339) | 2.93052117 |
| 54 | Gastrointestinal infarctions (HP:0005244) | 2.82804377 |
| 55 | Peritonitis (HP:0002586) | 2.75272179 |
| 56 | Hypoalphalipoproteinemia (HP:0003233) | 2.73243214 |
| 57 | Sensory axonal neuropathy (HP:0003390) | 2.69554607 |
| 58 | Recurrent fungal infections (HP:0002841) | 2.67153390 |
| 59 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.67076134 |
| 60 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.66967199 |
| 61 | Recurrent cutaneous fungal infections (HP:0011370) | 2.66967199 |
| 62 | Hypercholesterolemia (HP:0003124) | 2.64266022 |
| 63 | Fragile nails (HP:0001808) | 2.63961505 |
| 64 | Palmoplantar hyperkeratosis (HP:0000972) | 2.63799911 |
| 65 | Arterial thrombosis (HP:0004420) | 2.63634324 |
| 66 | Cholecystitis (HP:0001082) | 2.61258141 |
| 67 | Abnormal gallbladder physiology (HP:0012438) | 2.61258141 |
| 68 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.61242954 |
| 69 | Amyloidosis (HP:0011034) | 2.61215736 |
| 70 | Gingivitis (HP:0000230) | 2.59888808 |
| 71 | Subacute progressive viral hepatitis (HP:0006572) | 2.55878027 |
| 72 | Hemoptysis (HP:0002105) | 2.54958141 |
| 73 | Spastic paraparesis (HP:0002313) | 2.53339953 |
| 74 | Hypophosphatemic rickets (HP:0004912) | 2.52528522 |
| 75 | Pulmonary infiltrates (HP:0002113) | 2.52140957 |
| 76 | Glomerulonephritis (HP:0000099) | 2.51355810 |
| 77 | Fair hair (HP:0002286) | 2.50200329 |
| 78 | Vascular calcification (HP:0004934) | 2.49392561 |
| 79 | Abnormality of the intrinsic pathway (HP:0010989) | 2.47278037 |
| 80 | Spontaneous abortion (HP:0005268) | 2.47073290 |
| 81 | Pulmonary embolism (HP:0002204) | 2.46823764 |
| 82 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.45963789 |
| 83 | Epistaxis (HP:0000421) | 2.45403255 |
| 84 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.44572032 |
| 85 | Pustule (HP:0200039) | 2.42967227 |
| 86 | Palmar hyperkeratosis (HP:0010765) | 2.42743510 |
| 87 | Urticaria (HP:0001025) | 2.41622326 |
| 88 | Hyperbilirubinemia (HP:0002904) | 2.40832641 |
| 89 | Acanthocytosis (HP:0001927) | 2.40648063 |
| 90 | Atrophic scars (HP:0001075) | 2.40197276 |
| 91 | Cheilitis (HP:0100825) | 2.39274363 |
| 92 | Cerebral hemorrhage (HP:0001342) | 2.35747351 |
| 93 | Periodontitis (HP:0000704) | 2.35263368 |
| 94 | Abnormal gallbladder morphology (HP:0012437) | 2.33661199 |
| 95 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.33422170 |
| 96 | Episodic fever (HP:0001954) | 2.31863351 |
| 97 | Delayed CNS myelination (HP:0002188) | 2.31841523 |
| 98 | Abnormality of serum amino acid levels (HP:0003112) | 2.28592442 |
| 99 | Vasculitis (HP:0002633) | 2.27863641 |
| 100 | Spastic gait (HP:0002064) | 2.27501908 |
| 101 | Insidious onset (HP:0003587) | 2.27129889 |
| 102 | Termporal pattern (HP:0011008) | 2.27129889 |
| 103 | Hypoglycemic coma (HP:0001325) | 2.27030050 |
| 104 | Generalized hypopigmentation of hair (HP:0011358) | 2.26459990 |
| 105 | Abnormality of T cell number (HP:0011839) | 2.26264193 |
| 106 | Hyperglycinuria (HP:0003108) | 2.25619543 |
| 107 | Onion bulb formation (HP:0003383) | 2.24820065 |
| 108 | Increased cerebral lipofuscin (HP:0011813) | 2.24525012 |
| 109 | Cardiovascular calcification (HP:0011915) | 2.24277653 |
| 110 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.22323368 |
| 111 | Intention tremor (HP:0002080) | 2.21272706 |
| 112 | Skin nodule (HP:0200036) | 2.18984481 |
| 113 | Mediastinal lymphadenopathy (HP:0100721) | 2.18845282 |
| 114 | Abnormality of the axillary hair (HP:0100134) | 2.18405269 |
| 115 | Abnormality of secondary sexual hair (HP:0009888) | 2.18405269 |
| 116 | Blue irides (HP:0000635) | 2.18315517 |
| 117 | Increased IgE level (HP:0003212) | 2.17471548 |
| 118 | Abnormality of glycolysis (HP:0004366) | 2.17408509 |
| 119 | Increased serum pyruvate (HP:0003542) | 2.17408509 |
| 120 | Axonal loss (HP:0003447) | 2.17372136 |
| 121 | Confusion (HP:0001289) | 2.14122553 |
| 122 | Cerebral edema (HP:0002181) | 2.13355665 |
| 123 | Hypochromic microcytic anemia (HP:0004840) | 2.12859736 |
| 124 | Hypoplastic labia majora (HP:0000059) | 2.12806100 |
| 125 | Encephalitis (HP:0002383) | 2.12264173 |
| 126 | Abnormality of glycolipid metabolism (HP:0010969) | 2.10425807 |
| 127 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.10425807 |
| 128 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.10425807 |
| 129 | Mitral stenosis (HP:0001718) | 2.10355467 |
| 130 | Methylmalonic acidemia (HP:0002912) | 2.09780610 |
| 131 | T lymphocytopenia (HP:0005403) | 2.09322786 |
| 132 | Abnormal blistering of the skin (HP:0008066) | 2.08617870 |
| 133 | Metabolic acidosis (HP:0001942) | 2.08283126 |
| 134 | Scanning speech (HP:0002168) | 2.07782533 |
| 135 | Cholelithiasis (HP:0001081) | 2.07456951 |
| 136 | Spontaneous hematomas (HP:0007420) | 2.07221288 |
| 137 | Meningitis (HP:0001287) | 2.05218648 |
| 138 | Lower limb hyperreflexia (HP:0002395) | 2.04017334 |
| 139 | Systemic lupus erythematosus (HP:0002725) | 2.03917317 |
| 140 | Myocardial infarction (HP:0001658) | 2.03522834 |
| 141 | Chest pain (HP:0100749) | 2.01869733 |
| 142 | Rickets (HP:0002748) | 2.01707092 |
| 143 | Paraparesis (HP:0002385) | 2.01360540 |
| 144 | Opisthotonus (HP:0002179) | 2.01334808 |
| 145 | Prolonged bleeding time (HP:0003010) | 1.99900261 |
| 146 | Thrombophlebitis (HP:0004418) | 1.99645969 |
| 147 | Spastic tetraparesis (HP:0001285) | 1.98604561 |
| 148 | Irritability (HP:0000737) | 1.98533153 |
| 149 | Lethargy (HP:0001254) | 1.97412880 |
| 150 | Widely spaced teeth (HP:0000687) | 1.97036004 |
| 151 | Nephritis (HP:0000123) | 1.96671980 |
| 152 | Hyperventilation (HP:0002883) | 1.96123783 |
| 153 | Peripheral hypomyelination (HP:0007182) | 1.95731592 |
| 154 | Leukocytosis (HP:0001974) | 1.94937079 |
| 155 | Pruritus (HP:0000989) | 1.94375246 |
| 156 | Anorexia (HP:0002039) | 1.94293974 |
| 157 | Ketoacidosis (HP:0001993) | 1.92888743 |
| 158 | Abnormality of the labia majora (HP:0012881) | 1.92572961 |
| 159 | Peripheral demyelination (HP:0011096) | 1.92422593 |
| 160 | Dysmetria (HP:0001310) | 1.92175480 |
| 161 | Abnormality of vitamin metabolism (HP:0100508) | 1.89691948 |
| 162 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.89635249 |
| 163 | Choroideremia (HP:0001139) | 1.88895077 |
| 164 | Eosinophilia (HP:0001880) | 1.88716740 |
| 165 | Abnormality of the gallbladder (HP:0005264) | 1.87943382 |
| 166 | Dicarboxylic aciduria (HP:0003215) | 1.87297580 |
| 167 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.87297580 |
| 168 | Coronal craniosynostosis (HP:0004440) | 1.86982790 |
| 169 | Ectropion (HP:0000656) | 1.86861690 |
| 170 | Hepatocellular carcinoma (HP:0001402) | 1.86028624 |
| 171 | Viral hepatitis (HP:0006562) | 1.85368827 |
| 172 | Gingival bleeding (HP:0000225) | 1.85266738 |
| 173 | Nail dystrophy (HP:0008404) | 1.85248473 |
| 174 | Keratitis (HP:0000491) | 1.83900595 |
| 175 | Abnormality of the pleura (HP:0002103) | 1.83765236 |
| 176 | Infantile muscular hypotonia (HP:0008947) | 1.83629084 |
| 177 | Vacuolated lymphocytes (HP:0001922) | 1.83309280 |
| 178 | Brushfield spots (HP:0001088) | 1.83255180 |
| 179 | Stomach cancer (HP:0012126) | 1.82831145 |
| 180 | Supranuclear gaze palsy (HP:0000605) | 1.82325951 |
| 181 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.78515455 |
| 182 | Alkalosis (HP:0001948) | 1.78288393 |
| 183 | Turricephaly (HP:0000262) | 1.77303185 |
| 184 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.77287903 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 5.15918482 |
| 2 | FRK | 4.74872730 |
| 3 | OXSR1 | 3.77876943 |
| 4 | EPHB1 | 3.67453097 |
| 5 | BLK | 3.08054551 |
| 6 | FGFR2 | 2.74237885 |
| 7 | PKN1 | 2.61356893 |
| 8 | MAP3K2 | 2.50735759 |
| 9 | PBK | 2.49340082 |
| 10 | MAP3K3 | 2.40691103 |
| 11 | BCKDK | 2.40229525 |
| 12 | ERBB4 | 2.38827887 |
| 13 | MET | 2.19102407 |
| 14 | RIPK4 | 2.17524019 |
| 15 | EPHA4 | 2.06409307 |
| 16 | IRAK4 | 2.03529958 |
| 17 | TYK2 | 2.03240242 |
| 18 | BCR | 2.02639061 |
| 19 | SIK1 | 2.02516463 |
| 20 | MAP2K3 | 1.98518412 |
| 21 | TXK | 1.96158671 |
| 22 | TNIK | 1.90224716 |
| 23 | TGFBR2 | 1.85211823 |
| 24 | MAPKAPK5 | 1.82063627 |
| 25 | WNK4 | 1.68783321 |
| 26 | CASK | 1.68264916 |
| 27 | NTRK1 | 1.65206660 |
| 28 | JAK1 | 1.64720113 |
| 29 | ZAP70 | 1.59533616 |
| 30 | FGFR3 | 1.59228363 |
| 31 | CAMK2B | 1.57148176 |
| 32 | INSRR | 1.52162175 |
| 33 | CDK19 | 1.50177762 |
| 34 | FGFR4 | 1.39119956 |
| 35 | FGR | 1.35506155 |
| 36 | CSNK1G3 | 1.34479432 |
| 37 | BMPR2 | 1.34299844 |
| 38 | JAK3 | 1.33190518 |
| 39 | CSNK1A1L | 1.32143272 |
| 40 | MAP4K1 | 1.31468140 |
| 41 | IKBKE | 1.30963744 |
| 42 | FER | 1.30528190 |
| 43 | TESK2 | 1.30485851 |
| 44 | HCK | 1.29346565 |
| 45 | CSF1R | 1.26341531 |
| 46 | SGK494 | 1.26281229 |
| 47 | SGK223 | 1.26281229 |
| 48 | CAMK2G | 1.26050531 |
| 49 | JAK2 | 1.24593920 |
| 50 | CSNK1G2 | 1.23363408 |
| 51 | MAP3K13 | 1.21872432 |
| 52 | CSNK1G1 | 1.21719708 |
| 53 | MAP3K1 | 1.20561293 |
| 54 | KIT | 1.19429932 |
| 55 | IKBKB | 1.16931631 |
| 56 | WNK1 | 1.16836959 |
| 57 | MAP3K6 | 1.16342743 |
| 58 | ICK | 1.15886683 |
| 59 | SYK | 1.14094899 |
| 60 | PRPF4B | 1.13944986 |
| 61 | TAOK3 | 1.12128765 |
| 62 | CAMK2D | 1.12076443 |
| 63 | MATK | 1.07403500 |
| 64 | RAF1 | 1.04816666 |
| 65 | DAPK2 | 1.03903037 |
| 66 | LYN | 1.01720003 |
| 67 | MAPK15 | 1.01619102 |
| 68 | BTK | 1.01572122 |
| 69 | TNK2 | 1.01422834 |
| 70 | PRKCQ | 1.01276697 |
| 71 | GRK7 | 1.00929958 |
| 72 | YES1 | 1.00267305 |
| 73 | MAP2K4 | 1.00161148 |
| 74 | TEC | 0.98872515 |
| 75 | PDGFRB | 0.97857611 |
| 76 | GRK6 | 0.97328801 |
| 77 | PAK6 | 0.96751899 |
| 78 | PAK3 | 0.96321257 |
| 79 | TBK1 | 0.94607058 |
| 80 | CAMK2A | 0.94593438 |
| 81 | ROCK2 | 0.92508350 |
| 82 | MST1R | 0.92274650 |
| 83 | SGK3 | 0.91628391 |
| 84 | PDK2 | 0.87696123 |
| 85 | NTRK3 | 0.86468020 |
| 86 | TYRO3 | 0.86352231 |
| 87 | STK10 | 0.86230987 |
| 88 | NEK6 | 0.84169339 |
| 89 | PIK3CG | 0.84138444 |
| 90 | IRAK2 | 0.82404169 |
| 91 | LIMK1 | 0.82152455 |
| 92 | SGK2 | 0.82093023 |
| 93 | UHMK1 | 0.80859916 |
| 94 | ABL2 | 0.80394153 |
| 95 | LATS1 | 0.79663511 |
| 96 | LCK | 0.79590259 |
| 97 | ITK | 0.78816141 |
| 98 | PDPK1 | 0.78677894 |
| 99 | MARK2 | 0.78575519 |
| 100 | CLK1 | 0.77322461 |
| 101 | FES | 0.76046032 |
| 102 | ACVR1B | 0.75779217 |
| 103 | GSK3A | 0.75771872 |
| 104 | ADRBK2 | 0.75739087 |
| 105 | AKT3 | 0.73786715 |
| 106 | STK24 | 0.73387252 |
| 107 | ERN1 | 0.71978802 |
| 108 | ADRBK1 | 0.70993961 |
| 109 | MARK3 | 0.68690471 |
| 110 | CDK12 | 0.67077278 |
| 111 | MAP3K7 | 0.66895548 |
| 112 | STK38L | 0.66282310 |
| 113 | STK38 | 0.65583249 |
| 114 | IRAK1 | 0.65498665 |
| 115 | CDK5 | 0.62861743 |
| 116 | CAMKK2 | 0.62489872 |
| 117 | IRAK3 | 0.62171917 |
| 118 | KSR2 | 0.62030768 |
| 119 | CSK | 0.61585451 |
| 120 | PRKD1 | 0.61325710 |
| 121 | FLT3 | 0.59463444 |
| 122 | ABL1 | 0.58883713 |
| 123 | ERBB2 | 0.58759049 |
| 124 | PRKCE | 0.58438675 |
| 125 | CHUK | 0.58243338 |
| 126 | PDGFRA | 0.56738457 |
| 127 | PIK3CA | 0.56606236 |
| 128 | MAPK7 | 0.56404386 |
| 129 | PNCK | 0.56103138 |
| 130 | FYN | 0.55590399 |
| 131 | TGFBR1 | 0.53883423 |
| 132 | NEK9 | 0.51015729 |
| 133 | NLK | 0.50896860 |
| 134 | PRKCZ | 0.50402477 |
| 135 | SIK3 | 0.49727216 |
| 136 | MAP3K5 | 0.49695756 |
| 137 | ARAF | 0.49657583 |
| 138 | MUSK | 0.49610367 |
| 139 | MARK1 | 0.48971771 |
| 140 | MOS | 0.48409927 |
| 141 | PTK2B | 0.48187669 |
| 142 | PRKAA2 | 0.46946470 |
| 143 | MAPK4 | 0.46454111 |
| 144 | PRKG1 | 0.46449676 |
| 145 | PINK1 | 0.46190285 |
| 146 | RIPK1 | 0.46166641 |
| 147 | PRKCH | 0.46094995 |
| 148 | CDK14 | 0.45470943 |
| 149 | PRKACB | 0.44897399 |
| 150 | MAPK11 | 0.44592279 |
| 151 | PTK2 | 0.44310780 |
| 152 | CDK15 | 0.43603251 |
| 153 | MAPK12 | 0.43357363 |
| 154 | PDK1 | 0.42684835 |
| 155 | EPHA3 | 0.42449086 |
| 156 | CAMK1G | 0.41982154 |
| 157 | BMX | 0.41961333 |
| 158 | IGF1R | 0.41895373 |
| 159 | CDC42BPA | 0.41000778 |
| 160 | DYRK2 | 0.39134726 |
| 161 | PRKCG | 0.38756342 |
| 162 | RET | 0.38694824 |
| 163 | CDK18 | 0.38034413 |
| 164 | CSNK1D | 0.37405622 |
| 165 | NTRK2 | 0.37236541 |
| 166 | MAP3K14 | 0.37090235 |
| 167 | TRPM7 | 0.36500243 |
| 168 | GRK1 | 0.36361731 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.16691068 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.73447371 |
| 3 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.24676105 |
| 4 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.79382538 |
| 5 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.73455449 |
| 6 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.62388031 |
| 7 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.61688845 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.56831923 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.55347315 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.51054588 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.40617799 |
| 12 | Histidine metabolism_Homo sapiens_hsa00340 | 2.34145017 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.33432413 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.21849171 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.19319695 |
| 16 | Leishmaniasis_Homo sapiens_hsa05140 | 2.15836792 |
| 17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.15270641 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.10010186 |
| 19 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.08965543 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.06632472 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.96793806 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.95035298 |
| 23 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.92730905 |
| 24 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.91416047 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.82888332 |
| 26 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.76838466 |
| 27 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.76408212 |
| 28 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.74518775 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.73257044 |
| 30 | Tuberculosis_Homo sapiens_hsa05152 | 1.71567808 |
| 31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.68481705 |
| 32 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.67237716 |
| 33 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.62359510 |
| 34 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.61325008 |
| 35 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.60134891 |
| 36 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.60105923 |
| 37 | Retinol metabolism_Homo sapiens_hsa00830 | 1.60081086 |
| 38 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.55098702 |
| 39 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.53487977 |
| 40 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.49789052 |
| 41 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.45568460 |
| 42 | Pertussis_Homo sapiens_hsa05133 | 1.45433188 |
| 43 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.40608916 |
| 44 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.40507116 |
| 45 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.39886185 |
| 46 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.38306552 |
| 47 | Legionellosis_Homo sapiens_hsa05134 | 1.37805630 |
| 48 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.37592953 |
| 49 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.35093106 |
| 50 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.33775933 |
| 51 | Bile secretion_Homo sapiens_hsa04976 | 1.33276450 |
| 52 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.32802615 |
| 53 | Amoebiasis_Homo sapiens_hsa05146 | 1.31302806 |
| 54 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.31071332 |
| 55 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.29250761 |
| 56 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.26256718 |
| 57 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.25615945 |
| 58 | Measles_Homo sapiens_hsa05162 | 1.24333010 |
| 59 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.24008677 |
| 60 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.21747717 |
| 61 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.21012953 |
| 62 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.20087740 |
| 63 | Influenza A_Homo sapiens_hsa05164 | 1.15515764 |
| 64 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.13002012 |
| 65 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.12521941 |
| 66 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.11781382 |
| 67 | Other glycan degradation_Homo sapiens_hsa00511 | 1.10886292 |
| 68 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.09316437 |
| 69 | Allograft rejection_Homo sapiens_hsa05330 | 1.07479008 |
| 70 | Platelet activation_Homo sapiens_hsa04611 | 1.07433244 |
| 71 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.07065661 |
| 72 | ABC transporters_Homo sapiens_hsa02010 | 1.06323638 |
| 73 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.01577053 |
| 74 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.98898487 |
| 75 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.98742134 |
| 76 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.97542922 |
| 77 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.97189755 |
| 78 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.95629216 |
| 79 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.94881948 |
| 80 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.89900922 |
| 81 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.89309882 |
| 82 | Phagosome_Homo sapiens_hsa04145 | 0.87785429 |
| 83 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.87750890 |
| 84 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.86098239 |
| 85 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.85045831 |
| 86 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.83506459 |
| 87 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.81458576 |
| 88 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.81455998 |
| 89 | Hepatitis C_Homo sapiens_hsa05160 | 0.81235583 |
| 90 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.81176087 |
| 91 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81057861 |
| 92 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.77985963 |
| 93 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.76680248 |
| 94 | Insulin resistance_Homo sapiens_hsa04931 | 0.74931593 |
| 95 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.74740096 |
| 96 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.74219390 |
| 97 | Hepatitis B_Homo sapiens_hsa05161 | 0.72983200 |
| 98 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.71683442 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.70667079 |
| 100 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.70156295 |
| 101 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.69857830 |
| 102 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.68123260 |
| 103 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.67871838 |
| 104 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.67133304 |
| 105 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66325650 |
| 106 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.66175634 |
| 107 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.65151922 |
| 108 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.64860172 |
| 109 | Prion diseases_Homo sapiens_hsa05020 | 0.64650992 |
| 110 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.64539521 |
| 111 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.64065767 |
| 112 | Salmonella infection_Homo sapiens_hsa05132 | 0.63600679 |
| 113 | Asthma_Homo sapiens_hsa05310 | 0.62794212 |
| 114 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.62499146 |
| 115 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.62210138 |
| 116 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.61563503 |
| 117 | Focal adhesion_Homo sapiens_hsa04510 | 0.61228248 |
| 118 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.60629716 |
| 119 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.60272882 |
| 120 | Carbon metabolism_Homo sapiens_hsa01200 | 0.56556388 |
| 121 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.55077346 |
| 122 | Sulfur relay system_Homo sapiens_hsa04122 | 0.52828500 |
| 123 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.51873449 |
| 124 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.51510398 |
| 125 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51219971 |
| 126 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48863300 |
| 127 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48636461 |
| 128 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.48416987 |
| 129 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47737499 |
| 130 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.46916239 |
| 131 | Apoptosis_Homo sapiens_hsa04210 | 0.46497739 |
| 132 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.44220249 |
| 133 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.43817940 |
| 134 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.42629871 |
| 135 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.42265458 |
| 136 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.37055518 |
| 137 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35978873 |
| 138 | Lysine degradation_Homo sapiens_hsa00310 | 0.35172803 |
| 139 | GABAergic synapse_Homo sapiens_hsa04727 | 0.31794096 |
| 140 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.30627824 |
| 141 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.22850683 |
| 142 | Axon guidance_Homo sapiens_hsa04360 | 0.22302267 |
| 143 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.19659770 |
| 144 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.17576237 |
| 145 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.14586680 |
| 146 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.12509452 |
| 147 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.11485760 |
| 148 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.09898072 |
| 149 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.08526957 |
| 150 | Protein export_Homo sapiens_hsa03060 | 0.07925485 |
| 151 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.07829096 |
| 152 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.06669883 |
| 153 | Cocaine addiction_Homo sapiens_hsa05030 | 0.02576360 |
| 154 | Alzheimers disease_Homo sapiens_hsa05010 | 0.02167610 |
| 155 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.02033478 |
| 156 | Lysosome_Homo sapiens_hsa04142 | 0.01641116 |
| 157 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.01561836 |
| 158 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.00090261 |
| 159 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.0822921 |
| 160 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | -0.0681373 |
| 161 | Morphine addiction_Homo sapiens_hsa05032 | -0.0478137 |
| 162 | Mineral absorption_Homo sapiens_hsa04978 | -0.0459088 |
| 163 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0434831 |
| 164 | Long-term depression_Homo sapiens_hsa04730 | -0.0415477 |
| 165 | Malaria_Homo sapiens_hsa05144 | -0.0328499 |
| 166 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0273887 |
| 167 | Nicotine addiction_Homo sapiens_hsa05033 | -0.0145815 |
| 168 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.0133300 |

